Braver Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$3.5M Buy
23,908
+84
+0.4% +$12.6K 0.57% 53
2016
Q3
$3.97M Sell
23,824
-7,284
-23% -$1.23M 0.67% 46
2016
Q2
$4.73M Sell
31,108
-1,094
-3% -$170K 0.81% 30
2016
Q1
$4.83M Buy
32,202
+2,550
+9% +$379K 0.79% 36
2015
Q4
$4.81M Buy
29,652
+2,743
+10% +$431K 0.99% 25
2015
Q3
$3.72M Buy
26,909
+9,890
+58% +$1.56M 0.92% 29
2015
Q2
$2.61M Buy
17,019
+5,219
+44% +$836K 0.64% 33
2015
Q1
$1.89M Sell
11,800
-103
-0.9% -$16.2K 0.39% 53
2014
Q4
$1.9M Sell
11,903
-3,417
-22% -$532K 0.39% 45
2014
Q3
$2.15M Sell
15,320
-219
-1% -$28.6K 0.65% 25
2014
Q2
$1.84M Buy
15,539
+3,342
+27% +$387K 0.47% 35
2014
Q1
$1.5M Buy
+12,197
New +$1.48M 0.43% 38

Other funds holding AMGN

Braver Wealth Management's AMGN Position: Q4 2016 in Review

Braver Wealth Management increased its Amgen (AMGN) stake by 0.35% in Q4 2016, buying an estimated $12.6K and bringing the position to 23,908 shares worth $3.5M. The position accounts for 0.57% of the portfolio, ranked #53.

Braver Wealth Management first reported a position in AMGN in Q1 2014 and has held it in 12 quarters since. The position peaked at $4.83M in Q1 2016. 1,541 funds tracked by Wall St. Rank hold AMGN as of Q4 2016.

  • Braver Wealth Management held 23,908 shares of Amgen worth $3.5M as of Q4 2016.
  • Braver Wealth Management bought 84 Amgen shares in Q4 2016, an estimated $12.6K.
  • Amgen made up 0.57% of Braver Wealth Management's portfolio in Q4 2016, its #53 holding.
  • Braver Wealth Management first reported a position in Amgen in Q1 2014 and has held it in 12 quarters since.
  • Braver Wealth Management's Amgen position peaked at $4.83M in Q1 2016.
  • 1,541 funds tracked by Wall St. Rank held Amgen as of Q4 2016.

Based on Braver Wealth Management's 13F filing for Q4 2016, filed 14 Feb 2017.